Filter
568
Filtered Results: 568
Text search:
Medikamente
Featured
Recommendations
75
New Publications
105
Language
Document type
No document type
269
Studies & Reports
91
Guidelines
82
Fact sheets
39
Brochures
36
Resource Platforms
16
Strategic & Response Plan
12
Manuals
8
Training Material
8
Infographics
3
Dashboards/Maps
1
Situation Updates
1
App
1
Online Courses
1
Countries / Regions
Germany
177
Western and Central Europe
29
Global
18
Senegal
14
Indonesia
14
Congo, Democratic Republic of
12
Eastern Europe
12
Benin
11
Burkina Faso
9
Cameroon
6
Haiti
6
Latin America and the Carribbean
5
Africa
4
Togo
3
Mozambique
3
Guinea-Bissau
3
France
3
Mali
3
Angola
3
Switzerland
2
Colombia
2
Ukraine
2
Sierra Leone
2
Malawi
2
Guinea
2
Venezuela
2
West and Central Africa
2
Côte d’Ivoire / Ivory Coast
2
Liberia
2
Ecuador
2
India
2
Rwanda
1
Nigeria
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Asia
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Luxembourg
1
Belgium
1
East and Southern Africa
1
South Africa
1
Uganda
1
Djibouti
1
Romania
1
Central African Republic
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
117
Clinical Guidelines
27
Public Health
11
Women & Child Health
8
Key Resources
4
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
Refugee
193
Mental Health
60
TB
51
COVID-19
34
Global Health Education
34
Malaria
25
NCDs
24
Pharmacy
17
NTDs
10
HIV
9
Rapid Response
8
Caregiver
8
Planetary Health
8
Ebola & Marburg
7
Health Financing Toolbox
6
Conflict
5
AMR
3
Zika
2
Specific Hazards
1
Natural Hazards
1
Polio
1
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
The World Health Organization (WHO) launched the SAFER initiative in 2018 to address the global health and societal challenges posed by alcohol-related harm. The initiative outlines five key strategies aimed at reducing alcohol consumption and its associated consequences. These include strengthening...
The Federal Centre for Health Education (BZgA) emphasizes the critical role of drug prevention in enhancing public health in Germany. Annually, the country faces significant premature mortality due to substance use: at least 110,000 deaths from smoking, 40,000 from harmful alcohol consumption, and a...
The World Health Organization's fact sheet on opioid overdose highlights the significant global health issue posed by opioids, which include natural, semi-synthetic, and synthetic compounds used primarily for pain management. Misuse and unsupervised use can lead to dependence and severe health probl...
The pamphlet "Prescription Benzodiazepines" explains the uses, effects, and risks of benzodiazepines, commonly prescribed for insomnia, anxiety, and panic attacks. It describes how these drugs enhance GABA activity to suppress brain activity, leading to short-term effects like drowsiness and anxiety...
The World Health Organization's Eastern Mediterranean Regional Office (WHO EMRO) highlights the significant health and social consequences of harmful alcohol use. Excessive alcohol consumption is linked to over 200 diseases and injuries, including liver cirrhosis, pancreatitis, various cancers, hemo...
The pamphlet "Oxycodone" provides an overview of the opioid drug class, explaining its uses, effects, and risks. It describes positive effects like euphoria and pain relief, alongside negative effects such as respiratory depression, confusion, and constipation. Withdrawal symptoms include anxiety, i...
The report provides an overview of alcohol consumption, related health harm, and policy responses in 30 European countries (EU Member States, Norway, and Switzerland). It highlights the high levels of alcohol consumption in the WHO European Region, which contribute to a significant disease burden co...
The OECD's "Alcohol Consumption" indicator measures the annual sales of pure alcohol in liters per person aged 15 and older. This metric helps assess long-term trends in alcohol consumption across countries. It's important to note that the methodology for converting alcoholic beverages to pure alcoh...
The pamphlet "Methamphetamine" provides information about methamphetamine, an illegal stimulant with high abuse potential, though it has limited medical uses for conditions like ADHD and narcolepsy. It explains short-term effects such as appetite suppression, increased heart rate and blood pressure,...
Cardiovascular diseases (CVD) represent the highest burden of disease globally. Medicines are a critical intervention used to prevent and treat CVD. This review describes access to medication for CVD from a health system perspective and strategies that have been used to promote access, including pro...
Psychoactive drugs are substances that, when taken in or administered into one's system, affect mental processes, e.g. perception, consciousness, cognition or mood and emotions. Psychoactive drugs belong to a broader category of psychoactive substances that include also alcohol and nicotine. “Psy...
The World Health Organization (WHO) provides an overview of alcohol consumption and its global impact. Alcohol, containing ethanol, is a psychoactive and toxic substance that can lead to dependence. In 2019, alcohol consumption was responsible for approximately 2.6 million deaths worldwide, with 1.6...
The pamphlet "Alcohol and Depressants" explains the effects of depressants, including alcohol. Depressants slow brain activity by increasing the release of inhibitory neurotransmitters like GABA, leading to effects such as sedation, decreased anxiety, and reduced heart rate. Alcohol, a legal depress...
Demographic and socioeconomic data Progress towards HIV testing and treatment cascade targets by 2025 (2023) Health sector cascade (2023) Estimated number of people newly infected with HIV
The article "Capacity-Building in Community-Based Drug Treatment Services" by Michael J. Cole focuses on the global challenges in providing adequate community-based drug treatment services. It highlights the gaps in availability, quality, and accessibility of evidence-based care. The article discuss...
EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144.
Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and safe antimalarial treatments are essential, quinine — an older, less effective drug — has long bee...
Int. J. Transl. Med. 2023, 3(2), 187-202; https://doi.org/10.3390/jtm3020014 .
Malaria and HIV are geographically in the tropics and subtropics of the world, including sub-Saharan Africa. Understanding the overlapping effect of both infections, especially among pregnant women, is crucial in managin...
The webinars aim to create awareness and convene discussion, bringing together Malaria Consortium technical experts and programmes teams with other actors working on the effective delivery of national and global health interventions worldwide.
Malaria Journal (2024) 23:255. Seasonal malaria chemoprevention (SMC) is a World Health Organization-recommended intervention for the prevention of malaria among children at high risk in areas with seasonal transmission. During the coronavirus disease 2019 (COVID-19) pandemic, SMC drug distribution ...
